These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation. Zallio F; Primon V; Tamiazzo S; Pini M; Baraldi A; Corsetti MT; Gotta F; Bertassello C; Salvi F; Rocchetti A; Levis A Clin Transplant; 2013; 27(4):E491-7. PubMed ID: 23781897 [TBL] [Abstract][Full Text] [Related]
9. Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy. Wang Y; Aïssi-Rothe L; Virion JM; De Carvalho Bittencourt M; Ulas N; Audonnet S; Salmon A; Clement L; Venard V; Jeulin H; Stoltz JF; Decot V; Bensoussan D Cytotherapy; 2014 Jan; 16(1):122-34. PubMed ID: 24094498 [TBL] [Abstract][Full Text] [Related]
10. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders. Dolcetti R Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317 [TBL] [Abstract][Full Text] [Related]
11. [Latest update on immunotherapy of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease]. Hao QF; Sheng GY; Luan Z Zhongguo Dang Dai Er Ke Za Zhi; 2013 Sep; 15(9):795-9. PubMed ID: 24034931 [TBL] [Abstract][Full Text] [Related]
12. Treatment options for post-transplant lymphoproliferative disorder and other Epstein-Barr virus-associated malignancies. Davis JE; Moss DJ Tissue Antigens; 2004 Apr; 63(4):285-92. PubMed ID: 15009802 [TBL] [Abstract][Full Text] [Related]
13. Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment. Petrara MR; Giunco S; Serraino D; Dolcetti R; De Rossi A Cancer Lett; 2015 Dec; 369(1):37-44. PubMed ID: 26279520 [TBL] [Abstract][Full Text] [Related]
14. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055 [TBL] [Abstract][Full Text] [Related]